Drug shortages remain a thorn in the side of hospital pharmacy leaders nationwide, but one health system has found the right combination of tools to manage them. The American Society of Health-System Pharmacists reported 216 active drug shortages in early 2026,…
Pharmacy
The three largest pharmacy benefit managers — Caremark, Express Scripts and Optum Rx — each excluded more than 600 drugs from their 2026 formularies, reflecting shifts in drug pricing models that are beginning to challenge traditional formulary strategies, according to…
Oregon lawmakers have approved legislation allowing certain healthcare providers to operate licensed mobile pharmacies in a move to expand medication access in underserved areas. Under House Bill 4131, the state Board of Pharmacy would offer mobile pharmacy licenses to retail…
K.C. Pharmaceuticals has recalled more than 3 million over-the-counter eye drop bottles due to a lack of assurance of sterility. The Class II recall, initiated March 3, includes eight brands manufactured by K.C. and distributed nationwide under store-brand labels such…
President Donald Trump has imposed a 100% tariff on patented pharmaceutical products and their ingredients, escalating a multiyear push to shift drug manufacturing to the U.S., according to an April 2 White House news release. The move follows a Section…
Pfizer and BioNTech have halted a U.S. study of their updated COVID-19 vaccine in adults ages 50-64 due to slow enrollment, a Pfizer spokesperson confirmed to Becker’s. “We can confirm our communication to the FDA about the status of the…
The FDA has linked Amgen’s vasculitis drug Tavneos to 76 postmarketing cases of drug-induced liver injury, including eight deaths, 54 hospitalizations and 74 serious outcomes. Seven patients developed vanishing bile duct syndrome, three of whom died. The medication, approved in…
The 4th U.S. Circuit Court of Appeals upheld a preliminary injunction blocking West Virginia from enforcing a law requiring drugmakers to provide 340B drug discounts to contract pharmacies. The March 31 decision stems from a consolidated lawsuit filed in December…
Most pharmacy staffing conversations focus on filling the next shift. The bigger opportunity is building a workforce strategy that can absorb disruption without constant escalation. Short-term gaps, long-term vacancies, seasonal surges, and growth initiatives all require different responses, but many…
The FDA has approved a higher-dose regimen of Spinraza for spinal muscular atrophy, providing a new treatment option for patients. The regimen includes 50 milligram per 5 milliliter and 28 milligram per 5 milliliter doses and is designed to deliver…